By Emeritus Professor Michael Barton

Journal articles

Batumalai V; Shafiq J; Gabriel G; Hanna TP; Delaney GP; Barton M, 2018, 'Impact of radiotherapy underutilisation measured by survival shortfall, years of potential life lost and disability-adjusted life years lost in New South Wales, Australia', Radiotherapy and Oncology, 129, pp. 191 - 195, http://dx.doi.org/10.1016/j.radonc.2018.06.026

Liney GP; Whelan B; Oborn B; Barton M; Keall P, 2018, 'MRI-Linear Accelerator Radiotherapy Systems', Clinical Oncology, 30, pp. 686 - 691, http://dx.doi.org/10.1016/j.clon.2018.08.003

Rosenblatt E; Fidarova E; Zubizarreta EH; Barton MB; Jones GW; Mackillop WJ; Cordero L; Yarney J; Lim G; Gan JV; Cernea V; Stojanovic-Rundic S; Strojan P; Kochbati L; Quarneti A, 2018, 'Radiotherapy utilization in developing countries: An IAEA study', Radiotherapy and Oncology, 128, pp. 400 - 405, http://dx.doi.org/10.1016/j.radonc.2018.05.014

Barton MB; Gabriel GS; Delaney GP, 2018, 'Testing criterion-based benchmarking for the appropriate use of radiotherapy', Radiotherapy and Oncology, 128, pp. 406 - 410, http://dx.doi.org/10.1016/j.radonc.2018.05.023

Whelan B; Welgampola M; McGarvie L; Makhija K; Turner RM; Holloway L; Feain I; Jackson M; Barton M; Keall P, 2018, 'Patient reported outcomes of slow, single arc rotation: Do we need rotating gantries?', Journal of Medical Imaging and Radiation Oncology, 62, pp. 553 - 561, http://dx.doi.org/10.1111/1754-9485.12688

Liney GP; Dong B; Weber E; Rai R; Destruel A; Garcia-Alvarez R; Manton DJ; Jelen U; Zhang K; Barton M; Keall P; Crozier S, 2018, 'Imaging performance of a dedicated radiation transparent RF coil on a 1.0 Tesla inline MRI-linac', Physics in Medicine and Biology, 63, http://dx.doi.org/10.1088/1361-6560/aac813

Rosenblatt E; Fidarova E; Ghosh S; Zubizarreta E; Unterkirhere O; Semikoz N; Sinaika V; Kim V; Karamyan N; Isayev I; Akbarov K; Lomidze D; Bondareva O; Tuzlucov P; Zardodkhonova M; Tkachev S; Kislyakova M; Alimov J; Pidlubna T; Barton M; Mackillop W, 2018, 'Quality of radiotherapy services in post-Soviet countries: An IAEA survey', Radiotherapy and Oncology, 127, pp. 171 - 177, http://dx.doi.org/10.1016/j.radonc.2018.03.028

Rai R; Manton D; Jameson MG; Josan S; Barton MB; Holloway LC; Liney GP, 2018, '3D printed phantoms mimicking cortical bone for the assessment of ultrashort echo time magnetic resonance imaging:', Medical Physics, 45, pp. 758 - 766, http://dx.doi.org/10.1002/mp.12727

Borras JM; Grau C; Corral J; Wong K; Barton MB; Ferlay J; Bray F; Lievens Y, 2018, 'Estimating the number of fractions by tumour site for European countries in 2012 and 2025: An ESTRO-HERO analysis', Radiotherapy and Oncology, 126, pp. 198 - 204, http://dx.doi.org/10.1016/j.radonc.2017.11.009

Hanna TP; Shafiq J; Delaney GP; Vinod SK; Thompson SR; Barton MB, 2018, 'The population benefit of evidence-based radiotherapy: 5-Year local control and overall survival benefits', Radiotherapy and Oncology, 126, pp. 191 - 197, http://dx.doi.org/10.1016/j.radonc.2017.11.004

Yam C; Seth S; Hess KR; Mittendorf EA; Murthy RK; Damodaran S; Helgason T; Huo L; Thompson AM; Barton M; Huang ML; Arribas EM; Lane DL; Rauch GM; Adrada BE; Gilcrease MZ; Chang JT; Moulder SL, 2018, 'Impact of clinical, morphologic and molecular characteristics on response to neoadjuvant systemic therapy (NAST) in metaplastic breast cancer (MpBC)', Annals of Oncology, 29, pp. viii73 - viii74, http://dx.doi.org/10.1093/annonc/mdy270.223

Logeman CJ; Flanigan J; Foliaki S; Bray F; Barton M; Sitas F, 2017, 'Cancer in small states – No small matter', Cancer Epidemiology, 50, pp. 173 - 175, http://dx.doi.org/10.1016/j.canep.2017.09.005

Barton MB; Zubizarreta EH; Polo Rubio JA, 2017, 'Radiotherapy in small countries', Cancer Epidemiology, 50, pp. 257 - 259, http://dx.doi.org/10.1016/j.canep.2017.06.007

Pham TT; Liney G; Wong K; Rai R; Lee M; Moses D; Henderson C; Lin M; Shin JS; Barton MB, 2017, 'Study protocol: Multi-parametric magnetic resonance imaging for therapeutic response prediction in rectal cancer', BMC Cancer, 17, pp. 465, http://dx.doi.org/10.1186/s12885-017-3449-4

Whelan B; Liney GP; Dowling JA; Rai R; Holloway L; McGarvie L; Feain I; Barton M; Berry M; Wilkins R; Keall P, 2017, 'An MRI-compatible patient rotation system - Design, construction, and first organ deformation results:', Medical Physics, 44, pp. 581 - 588, http://dx.doi.org/10.1002/mp.12065

Barton MB; Zubizarreta E; Gospodarowicz M, 2017, 'Radiotherapy in Low- and Middle-income Countries. What Can We Do Differently?', Clinical Oncology, 29, pp. 69 - 71, http://dx.doi.org/10.1016/j.clon.2016.11.009

Yap ML; Hanna TP; Shafiq J; Ferlay J; Bray F; Delaney GP; Barton M, 2017, 'The Benefits of Providing External Beam Radiotherapy in Low- and Middle-income Countries', Clinical Oncology, 29, pp. 72 - 83, http://dx.doi.org/10.1016/j.clon.2016.11.003

Pham TT; Liney GP; Wong K; Barton MB, 2017, 'Functional MRI for quantitative treatment response prediction in locally advanced rectal cancer', British Journal of Radiology, 90, pp. 20151078, http://dx.doi.org/10.1259/bjr.20151078

Do V; Ng W; Jacob S; Delaney GP; Barton M, 2017, 'An estimation of the population survival benefit of first-course chemotherapy for head and neck cancers', Annals of Oncology, 28, pp. v388 - v388, http://dx.doi.org/10.1093/annonc/mdx374.043

Eduardo R; Gregorius BP; Michael B; Elena F; Jesper GE; Bruce H; Barbara AM; Anita B; Eduardo Z; May A-W; Barton M, 2017, 'Need for Competency-Based Radiation Oncology Education in Developing Countries', Creative Education, 08, pp. 66 - 80, http://dx.doi.org/10.4236/ce.2017.81006

Shafiq J; Hanna TP; Vinod SK; Delaney GP; Barton MB, 2016, 'A Population-based Model of Local Control and Survival Benefit of Radiotherapy for Lung Cancer', Clinical Oncology, 28, pp. 627 - 638, http://dx.doi.org/10.1016/j.clon.2016.05.006

Feain I; Shieh CC; White P; O'Brien R; Fisher S; Counter W; Lazarakis P; Stewart D; Downes S; Jackson M; Baxi S; Whelan B; Makhija K; Huang CY; Barton M; Keall P, 2016, 'Functional imaging equivalence and proof of concept for image-guided adaptive radiotherapy with fixed gantry and rotating couch', Advances in Radiation Oncology, 1, pp. 365 - 372, http://dx.doi.org/10.1016/j.adro.2016.10.004

Liney GP; Dong B; Begg J; Vial P; Zhang K; Lee F; Walker A; Rai R; Causer T; Alnaghy SJ; Oborn BM; Holloway L; Metcalfe P; Barton M; Crozier S; Keall P, 2016, 'Technical Note: Experimental results from a prototype high-field inline MRI-linac', Medical Physics, 43, pp. 5188 - 5194, http://dx.doi.org/10.1118/1.4961395

Hanna TP; Delaney GP; Barton MB, 2016, 'The population benefit of radiotherapy for gynaecological cancer: Local control and survival estimates', Radiotherapy and Oncology, 120, pp. 370 - 377, http://dx.doi.org/10.1016/j.radonc.2016.04.008

Hanna TP; Delaney GP; Barton MB, 2016, 'The population benefit of radiotherapy for malignant brain tumors: Local control and survival estimates for guideline-based use', JNCCN Journal of the National Comprehensive Cancer Network, 14, pp. 1111 - 1119, http://dx.doi.org/10.6004/jnccn.2016.0120

Borras JM; Lievens Y; Barton M; Corral J; Ferlay J; Bray F; Grau C, 2016, 'How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis', Radiotherapy and Oncology, 119, pp. 5 - 11, http://dx.doi.org/10.1016/j.radonc.2016.02.016

Thompson SR; Delaney GP; Jacob S; Shafiq J; Wong K; Hanna TP; Gabriel GS; Barton MB, 2016, 'Estimation of the optimal utilisation rates of radical prostatectomy, external beam radiotherapy and brachytherapy in the treatment of prostate cancer by a review of clinical practice guidelines', Radiotherapy and Oncology, http://dx.doi.org/10.1016/j.radonc.2015.12.023

Wong K; Delaney GP; Barton MB, 2016, 'Evidence-based optimal number of radiotherapy fractions for cancer: A useful tool to estimate radiotherapy demand', Radiotherapy and Oncology, http://dx.doi.org/10.1016/j.radonc.2015.12.001

Rodin D; Hanna TP; Burger E; Zubizarreta E; Yap ML; Barton M; Atun R; Knaul F; Van Dyk J; Lievens Y; Gospodarowicz M; Jaffray D; Milosevic M, 2016, '11: Global Access to Radiotherapy for Cervical Cancer: The Cost of Inaction', Radiotherapy and Oncology, 120, pp. S4 - S5, http://dx.doi.org/10.1016/s0167-8140(16)33410-7

Do V; Jacob S; Ng W; Delaney GP; Barton MB, 2016, '346P An estimation of the population survival benefit of first-course chemotherapy and immunotherapy for leukemia', Annals of Oncology, 27, pp. ix108 - ix108, http://dx.doi.org/10.1016/s0923-7534(21)00504-4

Yap ML; Zubizarreta E; Bray F; Ferlay J; Barton M, 2016, 'Global Access to Radiotherapy Services: Have We Made Progress During the Past Decade?', Journal of Global Oncology, 2, pp. 207 - 215, http://dx.doi.org/10.1200/jgo.2015.001545

Borras JM; Lievens Y; Barton M; Corral J; Ferlay J; Bray F; Grau C, 2016, 'OC-0331: How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis', Radiotherapy and Oncology, 119, pp. S153 - S153, http://dx.doi.org/10.1016/s0167-8140(16)31580-8

Borras JM; Dunscombe P; Barton M; Gasparotto C; Defourny N; Grau C; Lievens Y, 2015, 'ASSESSING THE GAP BETWEEN EVIDENCE BASED INDICATIONS FOR RADIOTHERAPY AND ACTUAL PRACTICE IN EUROPEAN COUNTRIES', VALUE IN HEALTH, 18, pp. A481 - A482, http://dx.doi.org/10.1016/j.jval.2015.09.1311

Gabriel G; Barton M; Delaney GP, 2015, 'The effect of travel distance on radiotherapy utilization in NSW and ACT', Radiotherapy and Oncology, 117, pp. 386 - 389, http://dx.doi.org/10.1016/j.radonc.2015.07.031

Atun R; Jaffray DA; Barton MB; Bray F; Baumann M; Vikram B; Hanna TP; Knaul FM; Lievens Y; Lui TYM; Milosevic M; O'Sullivan B; Rodin DL; Rosenblatt E; Van Dyk J; Yap ML; Zubizarreta E; Gospodarowicz M, 2015, 'Expanding global access to radiotherapy', The Lancet Oncology, 16, pp. 1153 - 1186, http://dx.doi.org/10.1016/S1470-2045(15)00222-3

Jaffray DA; Knaul FM; Atun R; Adams C; Barton MB; Baumann M; Lievens Y; Lui TYM; Rodin DL; Rosenblatt E; Torode J; van Dyk J; Vikram B; Gospodarowicz M, 2015, 'Global Task Force on Radiotherapy for Cancer Control', The Lancet Oncology, 16, pp. 1144 - 1146, http://dx.doi.org/10.1016/S1470-2045(15)00285-5

Kang YJ; O'Connell DL; Tan J; Lew JB; Demers A; Lotocki R; Kliewer EV; Hacker NF; Jackson M; Delaney GP; Barton M; Canfell K, 2015, 'Optimal uptake rates for initial treatments for cervical cancer in concordance with guidelines in Australia and Canada: Results from two large cancer facilities', Cancer Epidemiology, 39, pp. 600 - 611, http://dx.doi.org/10.1016/j.canep.2015.04.009

Rosenblatt E; Barton M; Mackillop W; Fidarova E; Cordero L; Yarney J; Lim G; Abad A; Cernea V; Stojanovic-Rundic S; Strojan P; Kobachi L; Quarneti A, 2015, 'Optimal radiotherapy utilisation rate in developing countries: An IAEA study', Radiotherapy and Oncology, 116, pp. 35 - 37, http://dx.doi.org/10.1016/j.radonc.2015.06.012

Borras JM; Barton M; Grau C; Corral J; Verhoeven R; Lemmens V; Van Eycken L; Henau K; Primic-Zakelj M; Strojan P; Trojanowski M; Dyzmann-Sroka A; Kubiak A; Gasparotto C; Defourny N; Malicki J; Dunscombe P; Coffey M; Lievens Y, 2015, 'The impact of cancer incidence and stage on optimal utilization of radiotherapy: Methodology of a population based analysis by the ESTRO-HERO project', Radiotherapy and Oncology, 116, pp. 45 - 50, http://dx.doi.org/10.1016/j.radonc.2015.04.021

Borras JM; Lievens Y; Dunscombe P; Coffey M; Malicki J; Corral J; Gasparotto C; Defourny N; Barton M; Verhoeven R; Van Eycken L; Primic-Zakelj M; Trojanowski M; Strojan P; Grau C, 2015, 'The optimal utilization proportion of external beam radiotherapy in European countries: An ESTRO-HERO analysis', Radiotherapy and Oncology, 116, pp. 38 - 44, http://dx.doi.org/10.1016/j.radonc.2015.04.018

Sitas F; Yap S; Egger S; Christian K; Hodgkinson V; Barton M; Banks E; Canfell K; O'Connell DL; Nair-Shalliker V, 2015, 'The Cancer, Lifestyle and Evaluation of Risk Study (CLEAR): Rationale and design of an unmatched "case-spouse control" study of over 10,000 participants in New South Wales, Australia', Cancer Epidemiology, 39, pp. 414 - 423, http://dx.doi.org/10.1016/j.canep.2015.03.006

Petrushevski AN; Gabriel GS; Hanna TP; Allen S; Allison RW; Barton MB, 2015, 'Factors affecting the use of single-fraction radiotherapy for the palliation of bone metastases in Australia', Clinical Oncology, 27, pp. 205 - 212, http://dx.doi.org/10.1016/j.clon.2014.11.027

Hanna TP; Shafiq J; Delaney GP; Barton MB, 2015, 'The population benefit of radiotherapy for cervical cancer: Local control and survival estimates for optimally utilized radiotherapy and chemoradiation', Radiotherapy and Oncology, 114, pp. 389 - 394, http://dx.doi.org/10.1016/j.radonc.2015.02.005

Delaney GP; Barton MB, 2015, 'Evidence-based Estimates of the Demand for Radiotherapy', Clinical Oncology, 27, pp. 70 - 76, http://dx.doi.org/10.1016/j.clon.2014.10.005

Jaffray DA; Atun R; Barton M; Baumann M; Gospodarowicz M; Hoskin P; Knaul FM; Lievens Y; Rosenblatt E; Torode J; Van Dyk J; Vikram B, 2015, 'Radiation Therapy and the Global Health Agenda', Clinical Oncology, 27, pp. 67 - 69, http://dx.doi.org/10.1016/j.clon.2014.11.025

Ng W; Jacob S; Delaney G; Do V; Barton M, 2015, 'Estimation of an optimal chemotherapy utilisation rate for upper gastrointestinal cancers: Setting an evidence-based benchmark for the best-quality cancer care', Gastroenterology Research and Practice, 2015, http://dx.doi.org/10.1155/2015/753480

Wong K; Delaney GP; Barton MB, 2015, 'Estimation of the optimal number of radiotherapy fractions for breast cancer: A review of the evidence', Radiotherapy and Oncology, 116, pp. 174 - 178, http://dx.doi.org/10.1016/j.radonc.2015.07.015

Thompson SR; Delaney GP; Gabriel GS; Barton MB, 2015, 'Patterns of care study of brachytherapy in New South Wales: Malignancies of the uterine corpus', Journal of Contemporary Brachytherapy, 7, pp. 224 - 230, http://dx.doi.org/10.5114/jcb.2015.52623

Do V; Jacob S; Ng W; Delaney GP; Barton MB, 2015, '120PD An estimation of the population-based survival benefit of first-line chemotherapy for adult primary malignant brain tumour', Annals of Oncology, 26, pp. ix34 - ix34, http://dx.doi.org/10.1093/annonc/mdv520.04

Do V; Ng W; Jacob S; Delaney G; Barton M, 2015, 'An Estimation of the Population-Based Survival Benefit of First-Line Chemotherapy for Lung Cancer', Annals of Oncology, 26, pp. i29 - i29, http://dx.doi.org/10.1093/annonc/mdv050.37

Back to profile page